Gilead Sciences, Inc. v. Cipla Ltd.
| Gilead Sciences, Inc. |
| Cipla Ltd. |
| 1:2026cv00990 |
| August 6, 2026 |
| U.S. District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 7, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 6 Summons Issued as to Cipla Ltd. on 8/7/2026. (slk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (slk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,346,841 B2. (slk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 29, 2026. Date of Expiration of Patent: U.S. Patent Nos. 8,754,065 and 9,296,769 expire on August 15, 2032. U.S. Patent Nos. 8,754,065 and 9,296,769 expire on February 15, 2033 with Pediatric Exclusivity (PED). U.S. Patent Nos. 8,664,386, 9,029,534 and 9,346,841 expire on October 3, 2032. U.S. Patent No. 9,777,028 expires on June 13, 2036..Thirty Month Stay Deadline: 12/29/2028. (slk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk) |
| Filing 1 COMPLAINT against Cipla Ltd. (Filing fee $ 405, receipt number ADEDC-5035846) - filed by Gilead Sciences, Inc. (Attachments: #1 Exhibits A-F, #2 Civil Cover Sheet)(slk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Gilead Sciences, Inc. v. Cipla Ltd. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Gilead Sciences, Inc. | |
| Represented By: | Megan Elizabeth Dellinger |
| Represented By: | Anthony David Raucci |
| Represented By: | Jeremy A. Tigan |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Cipla Ltd. | |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
